mTOR inhibitor salt forms

Details for Australian Patent Application No. 2009225614 (hide)

Owner OSI Pharmaceuticals, Inc

Inventors Visor, Gary C.; Castelhano, Arlindo L.; Mulvihill, Kristen Michelle; Rechka, Josef A.

Agent Spruson & Ferguson

Pub. Number AU-A-2009225614

PCT Pub. Number WO2009/117482

Priority 61/070,062 19.03.08 US

Filing date 18 March 2009

Wipo publication date 24 September 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/117482 Priority application(s): WO2009/117482

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225617-Optical method for determining morphological parameters and physiological properties of tissue

2009225611-Reduction of aldehydes in amines